Posaconazole mitigates α-amanitin-induced liver injury by inhibiting STT3B-mediated glycosylation and cellular uptake.

Front Pharmacol · 2026 · PMC13395608 · PMID 42499505

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Total bilirubin (TBIL) levels also showed a decreasing trend following treatment of posaconazole and ICG ( Figure 3E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.